ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
COMPASS Pathways PLC

COMPASS Pathways PLC (CMPS)

3.53
0.07
(2.02%)
3.59
0.06
( 1.70% )

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
3.59
( 1.70% )
Bid
3.55
Ask
3.59
Volume
344
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
3.53
Open
-
Last Trade
4
@
3.6
Last Trade Time
04:17:14
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
93,561,753
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
823k
Net Profit
-155.12M

About COMPASS Pathways PLC

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing ther... Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360. Show more

Sector
Offices-holdng Companies,nec
Industry
Offices-holdng Companies,nec
Headquarters
Cheshire, Gbr
Founded
-
COMPASS Pathways PLC is listed in the Offices-holdng Companies sector of the NASDAQ with ticker CMPS. The last closing price for COMPASS Pathways was $3.53. Over the last year, COMPASS Pathways shares have traded in a share price range of $ 0.00 to $ 0.00.

COMPASS Pathways currently has 93,561,753 shares outstanding. The market capitalization of COMPASS Pathways is $330.27 million.

CMPS Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

CMPS - Frequently Asked Questions (FAQ)

What is the current COMPASS Pathways share price?
The current share price of COMPASS Pathways is $ 3.59
How many COMPASS Pathways shares are in issue?
COMPASS Pathways has 93,561,753 shares in issue
What is the market cap of COMPASS Pathways?
The market capitalisation of COMPASS Pathways is USD 330.27M
What is the 1 year trading range for COMPASS Pathways share price?
COMPASS Pathways has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the reporting currency for COMPASS Pathways?
COMPASS Pathways reports financial results in USD
What is the latest annual turnover for COMPASS Pathways?
The latest annual turnover of COMPASS Pathways is USD 823k
What is the latest annual profit for COMPASS Pathways?
The latest annual profit of COMPASS Pathways is USD -155.12M
What is the registered address of COMPASS Pathways?
The registered address for COMPASS Pathways is 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE, WA14 2DT
What is the COMPASS Pathways website address?
The website address for COMPASS Pathways is www.compasspathways.com
Which industry sector does COMPASS Pathways operate in?
COMPASS Pathways operates in the OFFICES-HOLDNG COMPANIES,NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STKHSteakholder Foods Ltd
$ 4.04
(130.86%)
2.75M
CPOPPop Culture Group Company Ltd
$ 1.255
(80.58%)
3.53M
SUGPSU Group Holdings Ltd
$ 1.69
(38.52%)
1.94M
NCNANuCana PLC
$ 0.0768
(27.36%)
15.07M
NRIXNurix Therapeutics Inc
$ 16.04
(21.70%)
2.59k
MREOMereo BioPharma Group PLC
$ 1.885
(-35.88%)
21.88k
RAREUltragenyx Pharmaceutical Inc
$ 31.86
(-23.12%)
5.71k
CELZCreative Medical Technology Holdings Inc
$ 3.06
(-22.34%)
2.44k
NVFYNova Lifestyle Inc
$ 1.60
(-20.80%)
1.7k
EEIQEpicQuest Education Group International Ltd
$ 0.517
(-17.94%)
8.66k
NCNANuCana PLC
$ 0.0768
(27.36%)
15.07M
GIBOGIBO Holdings Ltd
$ 0.0404
(19.53%)
7.01M
CPOPPop Culture Group Company Ltd
$ 1.255
(80.58%)
3.53M
STKHSteakholder Foods Ltd
$ 4.04
(130.86%)
2.75M
SUGPSU Group Holdings Ltd
$ 1.69
(38.52%)
1.94M

CMPS Discussion

View Posts
georgie18 georgie18 1 week ago
CMPS...$3.11...🥳..Off my $2.36 Alert...

georgie18

Member Level
Re: georgie18 post# 394694

Wednesday, June 25, 2025 1:26:24 PM

Post#
394796
of 395004
CMPS...$2.74...🥳...Hit $2.82 Today...

georgie18

Member Level
Re: georgie18 post# 686778

Monday, June 23, 2025 7:45:19 PM

Post#
686830
of 687085
CMPS...$2.53...🥳

georgie18

Member Level
Re: None

Monday, June 23, 2025 2:39:09 PM

Post#
394682
of 394693
CMPS...$2.36...🥳...Taking a starter here... https://finance.yahoo.com/news/compass-psychedelic-drug-treat-depression-112820965.html
πŸ‘οΈ0
georgie18 georgie18 1 week ago
Yes Indeed...🥳
πŸ‘οΈ0
Outcast27 Outcast27 1 week ago
Looking very good, Great News today. Seems this treatment is going to be successful. I want some.
πŸ‘οΈ0
georgie18 georgie18 2 weeks ago
CMPS...$2.74...🥳...Hit $2.82 Today...

georgie18

Member Level
Re: georgie18 post# 686778

Monday, June 23, 2025 7:45:19 PM

Post#
686830
of 687085
CMPS...$2.53...🥳

georgie18

Member Level
Re: None

Monday, June 23, 2025 2:39:09 PM

Post#
394682
of 394693
CMPS...$2.36...🥳...Taking a starter here... https://finance.yahoo.com/news/compass-psychedelic-drug-treat-depression-112820965.html
πŸ‘οΈ0
Outcast27 Outcast27 2 weeks ago
Me too looks very good.
πŸ‘οΈ0
georgie18 georgie18 2 weeks ago
CMPS...$2.53...🥳

georgie18

Member Level
Re: None

Monday, June 23, 2025 2:39:09 PM

Post#
394682
of 394693
CMPS...$2.36...🥳...Taking a starter here... https://finance.yahoo.com/news/compass-psychedelic-drug-treat-depression-112820965.html
πŸ‘οΈ0
georgie18 georgie18 2 weeks ago
CMPS...$2.36...🥳...Taking a starter here... https://finance.yahoo.com/news/compass-psychedelic-drug-treat-depression-112820965.html
πŸ‘οΈ0
MomsSpaghetti MomsSpaghetti 2 weeks ago
Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

https://www.businesswire.com/news/home/20250623615674/en/Compass-Pathways-Successfully-Achieves-Primary-Endpoint-in-First-Phase-3-Trial-Evaluating-COMP360-Psilocybin-for-Treatment-Resistant-Depression
πŸ‘οΈ0
MomsSpaghetti MomsSpaghetti 4 weeks ago
Compass pathways announcing 6 new jobs 2 weeks prior to ph3 data readout.. interesting 🤔🚀

https://compasspathways.com/join-us/#careers

"Senior Manager, Packaging and Serialisation"
πŸ‘οΈ0
MomsSpaghetti MomsSpaghetti 2 months ago
Sector is on fire across the board!
πŸ‘οΈ0
MomsSpaghetti MomsSpaghetti 3 months ago
Now is the time to get in. CMPS MNMD ATAI
👍️ 1
MomsSpaghetti MomsSpaghetti 3 months ago
Heating up TLD data will be in 6 weeks. If positive (which it will be) - We will see the entire market in this sector erupt!
πŸ‘οΈ0
ListenToMe ListenToMe 6 months ago
The Psycedelic Bull run is about to begin. I agree 100 % 💯

Also keep an eye on tge psychedelic etf PSIL if you're looking for exposure to the sector but not sure which company to buy.
👍️ 1
LORTAP KCOTS LORTAP KCOTS 6 months ago
The whole group should be going up soon.
👍️ 1
ListenToMe ListenToMe 6 months ago
The time is near folks. $3.95 currently.

Cmps is about to start going g Up.
πŸ‘οΈ0
MomsSpaghetti MomsSpaghetti 8 months ago
ooof! Glad I didn't have this one. ATAI recently got rid of most of their share of CMPS which was good after this news.

MNMD and ATAI for the win in this sector.
πŸ‘οΈ0
dinogreeves dinogreeves 10 months ago
Awesome mid to long term hold. Could see 30-40 dollars by end of the year.
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
CMPS new 52 week high
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
CMPS new 52=week high
πŸ‘οΈ0
Copilotdog Copilotdog 2 years ago
There will be no mushroom boom. The Fed’s will crush it. Shorting this to $3
πŸ‘οΈ0
Monksdream Monksdream 2 years ago
This podcast is an absolute screaming hilarious analysis of psycho stocks
πŸ‘οΈ0
Monksdream Monksdream 2 years ago
Uh, you know, we live now in technology driven world
In times past ever since the Industrial Revolution wealth was created primarily from natural resources
But that isn’t exactly the etched in stone fact
Prior to the mid-1850s there was the Scientific Revolution that began in the 1400s
The academic discipline of chemistry in some unforeseen way led to the accidental discovery by a Swiss chemist who walked to his lab well into his 80s
That said, as far as US stock market sectors are concerned, the medical sector is by far the largest in terms of the number of companies in which a retail or professional asset manager deploying other people’s money can invest
Close to 1 000 public traded companies
It is in my view pretty much a crap shoot when it comes finding one that is equivalent to Microsoft
With that said one should, in the long run, expect disappointment to be the norm rather than the exception
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 2 years ago
Last time I owned this, was when I sold it over $70, really dodged a bullet on this one.. unfortunately I own MNMD.. and it’s just as bad of a fall down shit show
πŸ‘οΈ0
Monksdream Monksdream 2 years ago
CMPS new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 2 years ago
CMPS over $10

https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
πŸ‘οΈ0
Monksdream Monksdream 2 years ago
CMPS nearing resistance break it and it goes higher
πŸ‘οΈ0
Denisnj Denisnj 2 years ago
Definitely overpriced. Government needs slaves. No way they'll let humanity awaken
πŸ‘οΈ0
starman2 starman2 3 years ago
https://investorplace.com/2022/07/dear-psychedelic-stocks-fans-watch-this-key-catalyst/
πŸ‘οΈ0
starman2 starman2 3 years ago
https://www.benzinga.com/analyst-ratings/analyst-color/22/08/28522479/these-depression-players-are-hc-wainwrights-top-picks-for-400b-mental-healthcare-ma

(shared via bit.ly/mystocksapp)
πŸ‘οΈ0
starman2 starman2 3 years ago
On fire.. So glad i jumped in.
πŸ‘οΈ0
ListenToMe ListenToMe 3 years ago
Are you peeps watching PSYCF? I definitely think it's going to become the LEADER and Catalyst for the Mushroom sector!
πŸ‘οΈ0
ListenToMe ListenToMe 3 years ago
Best mushroom play is PSYCF!!! Pay Attn.


.PSYCF





.
πŸ‘οΈ0
ListenToMe ListenToMe 3 years ago
Awesome mushroom video & sound With its iconic red cap & white spots, our mushroom is the most recognizable mushroom in pop culture. It's often pictured in children's books, creating an association with magic and fairies, and tales told about the mushroom evoke an inner journey to the psyche.$PSYC $PSYC.C pic.twitter.com/XPTZXGY09C— Psyched Wellness (@PsychedWellness) January 5, 2022
πŸ‘οΈ0
BesaoT35 BesaoT35 4 years ago
Psychedelics are very safe drugs. A long term remission in treatment resistant major depression is a highly valuable and rare benefit to achieve for these patients.

On occasion there are reported cases of a psychosis induced, usually when that happens it is on very large doses of psychedelics perhaps combined with a non supportive environment.

Psilocybin causes fewer of these outcomes I have heard and is perhaps a less intense experience. Psilocybin is known to be a shorter acting psychedelic than LSD is.

Sedatives such as Valium or Xanax should be available if needed or desired at the end of the session in my opinion. Otherwise the process of coming down from the peak experience can be a drawn out and somewhat unpleasant process.
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 4 years ago
I love this stock!! Just flipped this for a $1500 profit in 24 hrs..
πŸ‘οΈ0
BesaoT35 BesaoT35 4 years ago
The clinical study for Treatment Resistant Major Depression looked very successful. Can a psychiatrist prescribe this patented psilocybin similar to how cannabis is illegal but medical doctors recommend it’s use legally for medical dispensaries?

How are they able to patent a known plant chemical? They claim to have a patented form of psilocybin.
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 4 years ago
Thank god I sold this.
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 4 years ago
This stock has really come back nicely!!
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 4 years ago
Awesome, just made $7700 on this trade!!!
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 4 years ago
Crushing upward today!!
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 4 years ago
Nice volume and nice price movement
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 4 years ago
This thing is moving up!!!
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 4 years ago
Big news today!!!
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 4 years ago
Steady increases, looks like we can get past $40 and then maybe $50?
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 4 years ago
WTF???
πŸ‘οΈ0
Glider549 Glider549 4 years ago
Sure was.
Schroom pharma is really advancing.
πŸ‘οΈ0
LORTAP KCOTS LORTAP KCOTS 4 years ago
Nice movement today
πŸ‘οΈ0
Tower of Hanoi Tower of Hanoi 4 years ago
Nice interview. Now that ketamine therapy is in use, I really don't see any significant roadblocks to further expansion into other drugs.

Execution will be critical, plus how many competitors end up in the space.
πŸ‘οΈ0
Investopotia Investopotia 4 years ago
New CEO Interview
πŸ‘οΈ0
Tower of Hanoi Tower of Hanoi 4 years ago
I can't think of a better speculative space right now!

GLTA!
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock